Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (pT3N0M0) prostate carcinoma

Clinical Cancer Research

Volumn 2, Issue 1, 1996, Pages 137-145

  Takahashi, Satoru ^a   Alcaraz, Antonio ^a   Brown, James A ^a   Borell, Thomas J ^b   Herath, John F ^b   Bergstralh, Erik J ^b   Lieber, Michael M ^a   Jenkins, Robert B ^b  

^a DEPARTMENT OF UROLOGY   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANEUPLOIDY; ARTICLE; CHROMOSOME 8; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; Y CHROMOSOME;

AGED; ANEUPLOIDY; CHROMOSOMES, HUMAN, PAIR 8; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; Y CHROMOSOME;

EID: 0030069763     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Gittes, R. F. Carcinoma of prostate. N. Eng. J. Med., 324: 236-245, 1991.
2. Shankey, V., Kallioniemi, O., Koslowski, J. M., Lieber, M. M., Mayall, B. H., Miller, G., and Smith, G. J. Consensus review of the clinical utility of DNA content cytometry in prostate cancer. Cytometry, 14: 497-500, 1993.
3. Devilee, P., Thierry, R. F., Kievits, T., Kolluri, R., Hopman, A. H. N., Willard, H. F., Pearson, P. L., and Cornelisse, C. J. Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumors using chromosome-specific repetitive DNA probes. Cancer Res., 48: 5825-5830, 1988.
4. Waldman, F. M., Carroll, P. R., Kerschmann, R., Cohen, M. B., Field, F. G., and Mayall, B. H. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res., 51: 3807-3813, 1991.
5. Persons, D. L., Gibney, D. J., Katzmann, J. A., Lieber, M M., Farrow, G. M., and Jenkins, R. B. Use of fluorescent in situ hybridization for deoxyribonucleic acid ploidy analysis of prostatic adenocarcinoma. J. Urol., 150: 120-125, 1993.
6. Brown, J. A., Alcaraz, A., Takahashi, S., Persons, D. L., Lieber, M. M., and Jenkins, R. B. Chromosomal aneusomies detected by fluorescence in situ hybridization (FISH) in clinically localized prostate carcinoma. J. Urol., 152: 1157-1162, 1994
7. Takahashi, S., Qian, J., Brown, J. A., Alcaraz, A., Bostwick, D. G., Lieber, M. M., and Jenkins, R. B. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Cancer Res., 54: 3574-3579, 1994.
8. Alcaraz, A., Takahashi, S., Brown, J. A., Herath, J. F., Bergstralh, E. J., Larson-Keller, J. J., Lieber, M. M., and Jenkins, R. B. Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res., 54: 3998-4002, 1994.
9. Utz, D. C., and Farrow, G. M Pathologic differentiation and prognosis of prostatic carcinoma. J. Am. Med. Assoc., 209: 1701-1703, 1969.
10. Zincke, H., Fleming, T. R., Furlow, W. L., Myers, R. P., and Utz, D. C. Radical retropubic prostatectomy and pelvic lymphadenectomy for high-stage cancer of the prostate. Cancer (Phila.), 47: 1901-1910, 1981.
11. Cheng, W. S., Frydenberg, M., Bergstralh, E. J., Larson-Keller, J. J., and Zincke, H. Radical prostatectomy for pathologic stage C prostate cancer: influence of pathologic variables and adjuvant treatment on disease outcome. Urology, 42: 283-291, 1993.
12. Nativ, O., Winkler, H. Z., Raz, Y , Therneau, T. M., Farrow, G. M., Myers, R. P., Zincke, H., and Lieber, M. M. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis. Mayo Clin. Proc., 64: 911-919, 1989.
13. Nativ, O., Myers, R. P., Farrow, G. M., Therneau, T. M., Zincke, H., and Lieber, M. M. Nuclear deoxyribonucleic acid ploidy and serum prostate specific antigen in operable prostatic adenocarcinoma. J. Urol., 144: 303-306, 1990.
14. Sandberg, A. A. Chromosome abnormalities and related events in prostate cancer. Hum. Pathol , 23: 368-380, 1992.
15. Lundgren, R., Mandahl, N., Heim, S., Limon, J., Henrikson, H., and Mitelman, F. Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosomes & Cancer, 4: 16-24, 1992.
16. Heim, S. Cytogenetics in the investigation of hematological disorders. Baillieres Clin. Hematol., 3: 921-948, 1990.
17. Walter, T. A., Berger, C. S., and Sandberg, A. A. The cytogenetics of renal tumors. Where do we stand, where do we go? Cancer Genet. Cytogenet., 43: 15-34, 1989.
18. Bigner, S. H., Mark, J., and Bigner, D. D. Cytogenetics of human brain tumors. Cancer Genet. Cytogenet., 47: 141-154, 1990.
19. Kovacs, G., and Frisch, S. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas. Cancer Res., 49: 651-659, 1989.
20. Breitkreuz, T., Romanakis, K., Lutz, S., Seitz, G., Bonkhoff, H., Unteregger, G., Zwergel, T., Zang, K. D., and Wullich, B. Genotypic characterization of prostatic carcinomas: a combined cytogenetic flow cytometry and in situ DNA hybridization study. Cancer Res., 53: 4035-4040, 1993.
21. Baretton, G. B., Vallina, C., Vogt, T., Schneiderbanger, K., Diebold, J., and Löhrs, U. Interphase cytogenetic analysis of prostatic carcinomas by use of nonisotopic in silu hybridization. Cancer Res., 54: 4472-4480, 1994
22. Emi, M., Fujiwara, Y., Nakajima, T., Tshuchiya, E., Tsuda, H., Hirohashi, S., Maeda, Y., Tsuruta, K., Miyaki, M., and Nakamura, Y. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res., 52: 5368-5372, 1992.
23. Fujiwara, Y., Emi, M., Ohata, H., Kato, Y., Nakajima, T., Mori, T., and Nakamura, Y., Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma. Cancer Res., 53: 1172-1174, 1993.
24. Bova, G. S., Carter, B. S., Bussemakers, M. J. G., Emi, M., Fujiwara, Y., Krprianou, N., Jacobs, S. C., Robinson, J. C., Epstein, J. I., Walsh, P. C., and Isaacs, W. B. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res., 53: 3869-3873, 1993.
25. Fujiwara, Y , Monden, M., Mori, T., Nakamura, Y., and Emi, M. Frequent multiplication of the long arm of chromosome 8 in hepatocellular carcinoma. Cancer Res., 53: 857-860, 1993.
26. Macoska, J. A., Micale, M. A., Sakr, W. A., Benson, P. D., and Wolman, S. R. Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis. Genes Chromosomes & Cancer, 8: 88-97, 1993.
27. Macoska, J. A., Trybus, T. M., Sakr, W. A., Wolf, M. C., Benson, P. D., Powell, I. J., and Pontes, J. E. Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res., 54: 3824-3830, 1994.
28. Matsuyama H., Pan, Y., Skoog, L., Tribukait, B., Naito, K., Ekman, P., Lichter, P., and Bergerheim, U. S. Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization. Oncogene, 9: 3071-3076, 1994.
29. Borg, Å., Baldetorp, B., Fernö, M., Olsson, H., and Sigurdsson, H. c-myc amplification is an independent prognostic factor in postmenopausal breast cancer. Int. J. Cancer, 51: 687-691, 1992.
30. Van Den Berg, C., Guan, X., Von Hoff, D., Jenkins, R. B., Bittner, M., Griffin, C., Kallioniemi, O., Visakorpi, T., McGill, J., Herath, J. F., Epstein, J., Sorosdy, M., Meltzer, P., and Trent, J. DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications. Clin. Cancer Res., 1: 11-18, 1995.
31. Bandyk, M. G., Zhao, L., Troncoso, P., Pisters, L. L., Palmer, J. L., von Eschenbach, A. C., Chung, L. W. K., and Liang, J. C. Trisomy 7: a potential cytogenetic marker of human prostate cancer progression. Genes Chromosomes & Cancer, 9: 19-27, 1994.
32. Zitzelsberger, H., Szücs, S., Weier, H. U., Lehmann, L., Braselmann, H., Enders, S., Schilling, A., Breul, J., Höfler, H., and Bauchinger, M. Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin-embedded tissue sections with centromere-specific DNA probes. J. Pathol., 172: 325-335, 1994.
33. Johansson, B., Heim, S., Mandahl, N., Mertens, F., and Mitelman, F. Trisomy 7 in nonneoplastic cells. Genes Chromosomes & Cancer, 6: 199-205, 1993.
34. Altman, D. G., Lausen, B., Sauerbrei, W., and Schumacher, M. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J. Natl. Cancer Inst., 86: 829-835, 1994.